title: BCSH guideline for the use of anti-D immunoglobulin for the  prevention of haemolytic disease of the fetus and newborn.
authors.forename: H
authors.initials: H
authors.lastname: Qureshi
authors.forename: E
authors.initials: E
authors.lastname: Massey
authors.forename: D
authors.initials: D
authors.lastname: Kirwan
authors.forename: T
authors.initials: T
authors.lastname: Davies
authors.forename: S
authors.initials: S
authors.lastname: Robson
authors.forename: J
authors.initials: J
authors.lastname: White
authors.forename: J
authors.initials: J
authors.lastname: Jones
authors.forename: S
authors.initials: S
authors.lastname: Allard
mesh_terms: D004899:Erythroblastosis, Fetal / Q000097:blood / Q000453:epidemiology / Q000517:prevention & control*; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage*; D007231:Infant, Newborn; D008297:Male; D011247:Pregnancy; D011263:Pregnancy Trimester, Third; D012204:Rh-Hr Blood-Group System / Q000097:blood; D018029:Rho(D) Immune Globulin / Q000008:administration & dosage*
chemical_list: D007155:Immunologic Factors; D012204:Rh-Hr Blood-Group System; D018029:Rho(D) Immune Globulin; C026410:Rho(D) antigen